Clinical Trials
75 trialsFeasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
University of California, Irvine
ARISTA
St. Antonius Hospital Gronau
PAROLA
Institut Claudius Regaud
Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
National Taipei University of Nursing and Health Sciences
LaserSAFE
University College, London
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
Massachusetts General Hospital
A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
Memorial Sloan Kettering Cancer Center
Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
Shanghai Zhongshan Hospital
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
M.D. Anderson Cancer Center
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
GRACIE
UNICANCER
DINGO
St Vincent's Hospital, Sydney
TALENT
Prostate Cancer Clinical Trials Consortium
CLIQQC
Société Algérienne de Formation et Recherche en Oncologie
PPSARP
Lithuanian University of Health Sciences
MIDAS-Prostate
University Health Network, Toronto
PRO-BOOST-LC
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer
Case Comprehensive Cancer Center
BACAP-2
University Hospital, Toulouse
Fezo-ADT
Brigham and Women's Hospital
Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
The Methodist Hospital Research Institute
DuTOC
Dutch Society of Physicians for Pulmonology and Tuberculosis
Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC
Mayo Clinic
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
PSMA PET for Surveillance After Focal Therapy
University of Chicago
ABRUPT 2
University of Milano Bicocca
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Stanford University
X-SMILE
University of Zurich
DESTINATION 2
The Netherlands Cancer Institute
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
AdventHealth
LUDOPATH
Jules Bordet Institute
The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer
First Affiliated Hospital of Fujian Medical University
Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2)
Samsung Medical Center
SPAR
Clinique Sainte Clotilde
MicroUSgFLA
University Health Network, Toronto
NICE-PSMA
Martini-Klinik am UKE GmbH
ARBOR
Fox Chase Cancer Center
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
IPIZA
Qilu Hospital of Shandong University
KP-CARAIBES
Centre Hospitalier Universitaire de la Guadeloupe
DE-CART
Fox Chase Cancer Center
68Ga-P16-093 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
First Affiliated Hospital of Fujian Medical University
68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
First Affiliated Hospital of Fujian Medical University
I-FLOAT
University of Chicago
TPIAT-01
University Hospital, Lille
Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)
Tianjin Medical University Second Hospital
An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma
National Cancer Center Hospital East
Shenqi Fuwei Mixture Combined With Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric Cancer
Hunan Cancer Hospital
SEQUEL
Hoosier Cancer Research Network
JUMP
Brigham and Women's Hospital